ICUI · Icu Medical Inc/De

$182.98 -0.13 (-0.07%) At close · Aug 14

Customer concentration — top customer 19% of revenue

One customer — 19% of revenue (the six months ended June 30, 2026)

“For the three and six months ended June 30, 2026, our consolidated worldwide net sales to a single distributor were 19%, and 19%, respectively, and for the three and six months ended June 30, 2025, were 19% and 18%.”

One customer — 19% of revenue (the three months ended June 30, 2026)

“For the three and six months ended June 30, 2026, our consolidated worldwide net sales to a single distributor were 19%, and 19%, respectively, and for the three and six months ended June 30, 2025, were 19% and 18%.”

One customer — 19% of revenue (the three months ended June 30, 2025)

“For the three and six months ended June 30, 2026, our consolidated worldwide net sales to a single distributor were 19%, and 19%, respectively, and for the three and six months ended June 30, 2025, were 19% and 18%.”

One customer — 18% of revenue (the six months ended June 30, 2025)

“For the three and six months ended June 30, 2026, our consolidated worldwide net sales to a single distributor were 19%, and 19%, respectively, and for the three and six months ended June 30, 2025, were 19% and 18%.”

View the 10-Q filed Aug 6, 2026

Market Cap

$4.58B

25.01M

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.

Insider Sentiment Score

Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.

Net buyers

-4

Net shares bought

-0.08%

Net buy value

-$3,366,541

Date	Insider	Role	Type	Security	Shares	Price	Value	After
2026-08-13	Woolson Daniel	VP, GM-Infusion Capital	Sell↓ Filing footnotes — Common Stock (Direct) All shares sold were sold at the exact price disclosed.	Common Stock	5,417	$181.33	$982,265	17,062
2026-08-12	Sousa Ben	Chief Information Officer	Sell↓ Filing footnotes — Common Stock (Direct) All shares sold were sold at the exact price disclosed.	Common Stock	2,250	$178.32	$401,209	3,076
2026-08-11	FINNEY ELISHA W	Director	Sell↓ Filing footnotes — Common Stock (Direct) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.4808 to $182.5701, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.	Common Stock	378	$182.48	$68,978	4,871
2026-08-11	Voigtlander Christian B.	Chief Operating Officer	Sell↓ Filing footnotes — Common Stock (Direct) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.85 to $183.03, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.	Common Stock	8,929	$182.93	$1,633,404	37,377
2026-05-22	Woolson Daniel	VP, GM-Infusion Capital	Sell↓ Filing footnotes — Common Stock (Direct) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.03 to $132.33, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.	Common Stock	2,123	$132.21	$280,685	22,479
2026-05-14	Sanzone Virginia Ruth	VP, General Counsel	Sell↓ Filing footnotes — Common Stock (Direct) All shares sold were sold at the exact price disclosed.	Common Stock	2,447	$124.08	$303,624	19,460
2026-05-13	KENNEDY KOLLEEN T	Director	Convert↓ Filing footnotes — Common Stock (Direct) These securities are Restricted Stock Units. There is neither a purchase price nor an exercise price for Restricted Stock Units. These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.	Common Stock	1,254	—	—	0
2026-05-13	Hoffmeister David F	Director	Convert↓ Filing footnotes — Common Stock (Direct) These securities are Restricted Stock Units. There is neither a purchase price nor an exercise price for the Restricted Stock Units. These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.	Common Stock	1,254	—	—	0
2026-05-13	Abbey Donald	EVP Global Business Services I	Convert↑ Filing footnotes — Common Stock (Direct) These securities are Restricted Stock Units.	Common Stock	1,254	—	—	6,004
2026-05-13	KENNEDY KOLLEEN T	Director	Convert↑ Filing footnotes — Common Stock (Direct) These securities are Restricted Stock Units. There is neither a purchase price nor an exercise price for Restricted Stock Units.	Common Stock	1,254	—	—	4,539
2026-05-13	Hoffmeister David F	Director	Award↑ Filing footnotes — Common Stock (Direct) These securities are Restricted Stock Units. There is neither a purchase price nor an exercise price for the Restricted Stock Units. These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.	Common Stock	1,475	—	—	1,475
2026-05-13	KENNEDY KOLLEEN T	Director	Award↑ Filing footnotes — Common Stock (Direct) These securities are Restricted Stock Units. There is neither a purchase price nor an exercise price for Restricted Stock Units. These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.	Common Stock	1,475	—	—	1,475
2026-05-13	Hernandez Laurie	Director	Convert↑ Filing footnotes — Common Stock (Direct) These securities are Restricted Stock Units. There is neither a purchase price nor an exercise price for the Restricted Stock Units.	Common Stock	1,254	—	—	4,862
2026-05-13	Greenberg David C.	Director	Award↑ Filing footnotes — Common Stock (Direct) These securities are Restricted Stock Units. There is neither a purchase price nor an exercise price for the Restricted Stock Units. These awards vest on the anniversary date of the date of the grant or the following annual stockholder meeting, whichever occurs first.	Common Stock	1,475	—	—	1,475
2026-05-13	Greenberg David C.	Director	Convert↓ Filing footnotes — Common Stock (Direct) These securities are Restricted Stock Units. There is neither a purchase price nor an exercise price for the Restricted Stock Units. These awards vest on the anniversary date of the date of the grant or the following annual stockholder meeting, whichever occurs first.	Common Stock	1,254	—	—	0
2026-05-13	FINNEY ELISHA W	Director	Convert↓ Filing footnotes — Common Stock (Direct) These securities are Restricted Stock Units. There is neither a purchase price nor an exercise price for the Restricted Stock Units. These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.	Common Stock	1,254	—	—	0
2026-05-13	FINNEY ELISHA W	Director	Convert↑ Filing footnotes — Common Stock (Direct) These securities are Restricted Stock Units. There is neither a purchase price nor an exercise price for the Restricted Stock Units.	Common Stock	1,254	—	—	5,249
2026-05-13	Abbey Donald	EVP Global Business Services I	Convert↓ Filing footnotes — Common Stock (Direct) These securities are Restricted Stock Units. There is neither a purchase price nor an exercise price for the Restricted Stock Units. These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.	Common Stock	1,254	—	—	0
2026-05-13	Hoffmeister David F	Director	Convert↑ Filing footnotes — Common Stock (Direct) These securities are Restricted Stock Units.	Common Stock	1,254	—	—	6,004
2026-05-13	FINNEY ELISHA W	Director	Award↑ Filing footnotes — Common Stock (Direct) These securities are Restricted Stock Units. There is neither a purchase price nor an exercise price for the Restricted Stock Units. These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.	Common Stock	1,475	—	—	1,475
2026-05-13	Abbey Donald	EVP Global Business Services I	Award↑ Filing footnotes — Common Stock (Direct) These securities are Restricted Stock Units. There is neither a purchase price nor an exercise price for the Restricted Stock Units. These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.	Common Stock	1,475	—	—	1,475
2026-05-13	Hernandez Laurie	Director	Award↑ Filing footnotes — Common Stock (Direct) These securities are Restricted Stock Units. There is neither a purchase price nor an exercise price for the Restricted Stock Units. These awards vest on the anniversary of the date of the grant or the following stockholder meeting, whichever occurs first.	Common Stock	1,475	—	—	1,475
2026-05-13	Hernandez Laurie	Director	Convert↓ Filing footnotes — Common Stock (Direct) These securities are Restricted Stock Units. There is neither a purchase price nor an exercise price for the Restricted Stock Units. These awards vest on the anniversary of the date of the grant or the following stockholder meeting, whichever occurs first.	Common Stock	1,254	—	—	0
2026-05-13	Greenberg David C.	Director	Convert↑ Filing footnotes — Common Stock (Direct) These securities are Restricted Stock Units.	Common Stock	1,254	—	—	9,214
2026-05-12	Greenberg David C.	Director	Convert↑	Common Stock	2,424	$101.06	$244,969	10,384
2026-05-12	Greenberg David C.	Director	Convert↓	Non-Qualified Stock Option (right to buy)	2,424	—	—	0
2026-05-12	Greenberg David C.	Director	Sell↓ Filing footnotes — Common Stock (Direct) All shares sold were at the exact price disclosed.	Common Stock	2,424	$122.91	$297,934	7,960
2026-03-25	Abbey Donald	EVP Global Business Services I	Other↓ Filing footnotes — Common Stock (Direct) Represents transfer of shares of common stock by the reporting person pursuant to a domestic relations order. The reporting person no longer has a reportable beneficial interest in the shares transferred.	Common Stock	704	—	—	4,046
2026-03-15	Voigtlander Christian B.	Chief Operating Officer	Convert↓ Filing footnotes — Performance Shares (Direct) These Securities are Performance-based Restricted Stock Units (PRSU). There is neither a purchase price nor an exercise price for the PRSUs. Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein.	Performance Shares	11,400	—	—	0
2026-03-15	Jain Vivek	Director	Convert↑ Filing footnotes — Common Stock (Direct) These Securities are Performance-based Restricted Stock Units (PRSU). Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein.	Common Stock	17,100	—	—	134,106
2026-03-15	Bonnell Brian Michael	Chief Financial Officer	Convert↑ Filing footnotes — Common Stock (Direct) These Securities are Performance-based Restricted Stock Units (PRSU). Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein.	Common Stock	11,400	—	—	76,097
2026-03-15	Voigtlander Christian B.	Chief Operating Officer	Tax↓	Common Stock	6,301	$125.85	$792,981	44,853
2026-03-15	Woolson Daniel	VP, GM-Infusion Capital	Convert↓ Filing footnotes — Performance Shares (Direct) These Securities are Performance-based Restricted Stock Units (PRSU). There is neither a purchase price nor an exercise price for the PRSUs. These PRSUs were granted on May 17, 2023. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 15 of the first, second, and third year following the year of grant.	Performance Shares	2,924	—	—	0
2026-03-15	Jain Vivek	Director	Convert↓ Filing footnotes — Performance Shares (Direct) These Securities are Performance-based Restricted Stock Units (PRSU). There is neither a purchase price nor an exercise price for the PRSUs. Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein.	Performance Shares	17,100	—	—	0
2026-03-15	Sousa Ben	Chief Information Officer	Tax↓	Common Stock	718	$125.85	$90,360	5,326
2026-03-15	Voigtlander Christian B.	Chief Operating Officer	Convert↑ Filing footnotes — Common Stock (Direct) These Securities are Performance-based Restricted Stock Units (PRSU). Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein.	Common Stock	11,400	—	—	51,154
2026-03-15	Jain Vivek	Director	Convert↓ Filing footnotes — Common Stock (Direct) These securities are Restricted Stock Units. There is neither a purchase price nor an exercise price for the Restricted Stock Units.	Common Stock	4,872	—	—	0
2026-03-15	Bonnell Brian Michael	Chief Financial Officer	Tax↓ Filing footnotes — Common Stock (Direct) These Securities are Performance-based Restricted Stock Units (PRSU).	Common Stock	5,800	$125.85	$729,930	70,297
2026-03-15	Voigtlander Christian B.	Chief Operating Officer	Convert↑ Filing footnotes — Common Stock (Direct) These securities are Restricted Stock Units.	Common Stock	3,248	—	—	48,101
2026-03-15	Sanzone Virginia Ruth	VP, General Counsel	Convert↑ Filing footnotes — Common Stock (Direct) These securities are Restricted Stock Units.	Common Stock	1,624	—	—	22,804
2026-03-15	Sanzone Virginia Ruth	VP, General Counsel	Convert↓ Filing footnotes — Performance Shares (Direct) These Securities are Performance-based Restricted Stock Units (PRSU). There is neither a purchase price nor an exercise price for the PRSUs. Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein.	Performance Shares	5,700	—	—	0
2026-03-15	Sousa Ben	Chief Information Officer	Convert↑ Filing footnotes — Common Stock (Direct) These securities are Restricted Stock Units.	Common Stock	1,300	—	—	6,044
2026-03-15	Sousa Ben	Chief Information Officer	Convert↓ Filing footnotes — Common Stock (Direct) These securities are Restricted Stock Units. There is neither a purchase price nor an exercise price for the Restricted Stock Units.	Common Stock	1,300	—	—	0
2026-03-15	Sanzone Virginia Ruth	VP, General Counsel	Tax↓ Filing footnotes — Common Stock (Direct) These Securities are Performance-based Restricted Stock Units (PRSU).	Common Stock	3,150	$125.85	$396,428	21,180
2026-03-15	Woolson Daniel	VP, GM-Infusion Capital	Tax↓	Common Stock	1,295	$125.85	$162,976	24,602
2026-03-15	Woolson Daniel	VP, GM-Infusion Capital	Convert↑ Filing footnotes — Common Stock (Direct) These Securities are Performance-based Restricted Stock Units (PRSU).	Common Stock	2,924	—	—	25,897
2026-03-15	Bonnell Brian Michael	Chief Financial Officer	Convert↑ Filing footnotes — Common Stock (Direct) These securities are Restricted Stock Units.	Common Stock	3,248	—	—	73,545
2026-03-15	Bonnell Brian Michael	Chief Financial Officer	Tax↓	Common Stock	1,795	$125.85	$225,901	71,750
2026-03-15	Jain Vivek	Director	Tax↓ Filing footnotes — Common Stock (Direct) These securities are Restricted Stock Units.	Common Stock	2,693	$125.85	$338,914	126,833
2026-03-15	Jain Vivek	Director	Convert↑ Filing footnotes — Common Stock (Direct) These securities are Restricted Stock Units.	Common Stock	4,872	—	—	129,526

Legend Buy — open-market purchase Sell — open-market sale ↑ Shares acquired ↓ Shares disposed (gift, conversion, tax…)

Showing 1–50 of 972 transactions

Key facts CIK 883984 CUSIP 44930G107 13F (30d) 263 filings 262 filers Visit website Investor relations